Cingulate (CINGW) Shares Outstanding (Diluted) (2022 - 2026)
Powered by 
Analysis
Cingulate (CINGW) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.32 Bn | 623.56 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 440.60 Bn | 434.04 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 365.39 Bn | 358.25 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Pfizer | 159.22 Bn | 147.52 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | 1.23 Bn |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - | 210.89 Mn |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn | 208.22 Mn |
| 9 | United Therapeutics | 21.49 Bn | 18.82 Bn | 683.80 Mn | 45.80 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 13.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.19 Mn |
| Dec 31, 2025 | 5.06 Mn |
| Sep 30, 2025 | 5.43 Mn |
| Jun 30, 2025 | 4.39 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 586,313.00 |
| Mar 31, 2024 | 412,109.00 |
| Dec 31, 2023 | 75,432.00 |
| Sep 30, 2023 | 82,358.00 |
| Jun 30, 2023 | 48,726.00 |
| Mar 31, 2023 | 47,121.00 |
| Dec 31, 2022 | 50,193.00 |
| Sep 30, 2022 | 47,121.00 |
| Jun 30, 2022 | 47,121.00 |